Responsible for all aspects of market research including initiation of the RFP process, vendor selection, study design, contract execution, budget management,…From ACADIA Pharmaceuticals Inc. – Wed, 19 Oct 2016 05:50:19 GMT – View all San Diego jobs
SAN FRANCISCO, Oct. 18, 2016 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) (“Nektar”) today announced the pricing of its previously announced underwritten public offering of $175.5 million in aggregate gross proceeds, or 13,000,000 shares of its common stock at a public offering price of $13.50 per share. In connection with this offering, Nektar has also granted to the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of common stock at the offering price.
J.P. Morgan is acting as lead book-running manager in the offering. Jefferies and Piper Jaffray are acting as book-running managers. William Blair is acting as lead manager for the offering, and Brean Capital, BTIG, Janney Montgomery Scott, Ladenburg Thalmann and ROTH Capital Partners are acting as co-managers for the offering.
Nektar intends to use the net proceeds from this offering for general corporate purposes including research and development funding and working capital.
The securities described above are being offered by Nektar pursuant to an effective shelf registration statement, including a prospectus supplement and accompanying prospectus, copies of which may be obtained from the offices of J.P. Morgan Securities LLC, attention Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York, NY 11717, or telephone: 866-803-9204.
This press release does not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Jennifer Ruddock 415-482-5585
SOURCE Nektar Therapeutics
We are currently looking for an In Vitro RA to work for a leading San Diego biotechnology company. BioPhase Solutions specializes in recruiting top talented…From BioPhase Solutions – Wed, 19 Oct 2016 01:43:17 GMT – View all San Diego jobs
We are currently working with a public biotech company who has an immediate opportunity for an Associate Director of SEC and Financial Reporting ….From Vaco – Wed, 19 Oct 2016 01:32:48 GMT – View all San Diego jobs
Marine Science Instructor at SEACAMP San Diego
We are looking to full-time staff that will be able to commit to a position beginning January 12, 2017 through mid-August 2017, with the possibility to extend.
Job Duties include (but are […
Production Associate II – Master Mixes & ASR – TEMP ONLY – Invivoscribe Technologies, Inc. – San Diego, CA
Customers include many of the world’s leading pharmaceutical and biotechnology companies, medical centers, cancer research centers, reference laboratories and…
From Indeed – Tue, 18 Oct 2016 22:14:46 GMT – View all San Diego jobs
Invivoscribe Technologies, Inc., is a privately-held corporation dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular research, molecular diagnostics, and personalized molecu […
Is a premier pharmaceutical chemistry development and manufacturing organization supporting the pharmaceutical and biotechnology industries….From Pharmatek Laboratories – Tue, 18 Oct 2016 21:50:59 GMT – View all San Diego jobs
Your projects will benefit from agile methodologies, pattern-based design, and the latest software technologies….From Illumina, Inc. – Tue, 18 Oct 2016 19:53:18 GMT – View all San Diego jobs
We are currently looking for an Animal Technician I to work for a leading San Diego biotechnology company….From BioPhase Solutions – Tue, 18 Oct 2016 19:42:54 GMT – View all San Diego jobs